Cancer Genomics - Proteomics: 9 (2)

March-April 2012; Volume 9,Issue 2

You have access
Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas

Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;
You have access
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara

Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
You have access
Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra

Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;
You have access
Proteomic Analysis of Differently Archived Breast Cancer Tissues
AC. Bougnoux, A. Mange and J. Solassol

Cancer Genomics & Proteomics March 2012, 9 (2) 93-99;
You have access
Proteomic Identification of Chaperonin-containing Tail-less Complex Polypeptide-1 Gamma Subunit as a p53-responsive Protein in Colon Cancer Cells
Shao Chin Lee and Jason Chan

Cancer Genomics & Proteomics March 2012, 9 (2) 101-108;

Main menu